Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

2.4K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.4K
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

1.5K
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
1.5K
Roles of Electrolytes: Calcium and Phosphate01:27

Roles of Electrolytes: Calcium and Phosphate

3.5K
Calcium and phosphate are essential electrolytes in the human body, with calcium being the most abundant mineral. Around 99% of the body's calcium is stored in the skeleton and teeth, forming a crystal lattice of mineral salts in combination with phosphates. Calcium plays crucial roles in various bodily functions such as blood clotting, neurotransmitter release, muscle tone maintenance, and nervous and muscle tissue excitability.
The calcium concentration in blood plasma is primarily...
3.5K
Clot Retraction and Fibrinolysis01:16

Clot Retraction and Fibrinolysis

10.2K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
10.2K
Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

15.6K
Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
15.6K
Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

700
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
700

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Addressing the pathophysiology of venous thrombosis and chronic kidney disease in sickle cell trait using a mouse model.

Blood advances·2025
Same author

A new look at TFPI inhibition of factor X activation.

PLoS computational biology·2024
Same author

Stopping the bleed when platelets don't stick.

Nature cardiovascular research·2024
Same author

Blood coagulation factor IX: structural insights impacting hemophilia B therapy.

Blood·2024
Same author

Protease: Serpin complexes to assess contact system and intrinsic pathway activation.

Research and practice in thrombosis and haemostasis·2020
Same author

Excessive breakthrough bleeding in haemophilia B patients on factor IX-albumin fusion protein prophylactic therapy: A single centre case series.

Haemophilia : the official journal of the World Federation of Hemophilia·2019

Related Experiment Video

Updated: Apr 3, 2026

Ferric Chloride-induced Murine Thrombosis Models
10:37

Ferric Chloride-induced Murine Thrombosis Models

Published on: September 5, 2016

23.5K

Polyphosphates rock! A role in thrombosis?

Dougald M Monroe1

  • 1UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL.

Blood
|September 19, 2015
PubMed
Summary

Factor XIa and polyphosphate significantly contribute to thrombus formation in human blood. These findings highlight factor XIa and polyphosphate as key targets for developing new antithrombotic therapies.

Area of Science:

  • Hematology
  • Vascular Biology
  • Thrombosis Research

Background:

  • Thrombosis, or clot formation, is a major cause of cardiovascular disease.
  • Understanding the molecular mechanisms driving thrombus formation is crucial for developing effective treatments.
  • Factor XIa and polyphosphate are implicated in coagulation but their precise roles in thrombus formation require further elucidation.

Purpose of the Study:

  • To investigate the contribution of factor XIa and polyphosphate to thrombus formation in human blood.
  • To identify key molecular players in thrombus development for potential therapeutic targeting.

Main Methods:

  • The study utilized human blood samples.
  • Experimental methods were employed to assess the roles of factor XIa and polyphosphate in thrombus generation.

More Related Videos

Assaying for Inorganic Polyphosphate in Bacteria
07:20

Assaying for Inorganic Polyphosphate in Bacteria

Published on: January 21, 2019

9.4K
Chemical Triphosphorylation of Oligonucleotides
13:19

Chemical Triphosphorylation of Oligonucleotides

Published on: June 2, 2022

4.3K

Related Experiment Videos

Last Updated: Apr 3, 2026

Ferric Chloride-induced Murine Thrombosis Models
10:37

Ferric Chloride-induced Murine Thrombosis Models

Published on: September 5, 2016

23.5K
Assaying for Inorganic Polyphosphate in Bacteria
07:20

Assaying for Inorganic Polyphosphate in Bacteria

Published on: January 21, 2019

9.4K
Chemical Triphosphorylation of Oligonucleotides
13:19

Chemical Triphosphorylation of Oligonucleotides

Published on: June 2, 2022

4.3K

Main Results:

  • Factor XIa was found to be a significant contributor to thrombus formation.
  • Polyphosphate also plays a substantial role in the development of blood clots.
  • The combined action of factor XIa and polyphosphate is critical for efficient thrombus development.

Conclusions:

  • Factor XIa and polyphosphate are key drivers of thrombus formation in human blood.
  • Targeting factor XIa and/or polyphosphate presents a promising therapeutic strategy for preventing thrombosis.
  • Further research into these targets could lead to novel antithrombotic agents.